Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli
- PMID: 11302826
- PMCID: PMC90504
- DOI: 10.1128/AAC.45.5.1550-1552.2001
Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli
Abstract
The amount of acrB, marA, and soxS mRNA was determined in 36 fluoroquinolone-resistant E. coli from humans and animals, 27 of which displayed a multiple-resistance phenotype. acrB mRNA was elevated in 11 of 36 strains. A mutation at codon 45 (Arg-->Cys) in acrR was found in 6 of these 11 strains. Ten of the 36 isolates appeared to overexpress soxS, and five appeared to overexpress marA. A number of mutations were found in the marR and soxR repressor genes, correlating with greater amounts of marA and soxS mRNA, respectively.
Figures


Similar articles
-
Autoactivation of the marRAB multiple antibiotic resistance operon by the MarA transcriptional activator in Escherichia coli.J Bacteriol. 1996 Apr;178(8):2216-23. doi: 10.1128/jb.178.8.2216-2223.1996. J Bacteriol. 1996. PMID: 8636021 Free PMC article.
-
Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli.Antimicrob Agents Chemother. 1998 Aug;42(8):2089-94. doi: 10.1128/AAC.42.8.2089. Antimicrob Agents Chemother. 1998. PMID: 9687412 Free PMC article.
-
Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.Antimicrob Agents Chemother. 2001 May;45(5):1515-21. doi: 10.1128/AAC.45.5.1515-1521.2001. Antimicrob Agents Chemother. 2001. PMID: 11302820 Free PMC article.
-
Improvement of organic solvent tolerance level of Escherichia coli by overexpression of stress-responsive genes.Extremophiles. 1998 Aug;2(3):239-48. doi: 10.1007/s007920050066. Extremophiles. 1998. PMID: 9783171 Review.
-
Overlaps and parallels in the regulation of intrinsic multiple-antibiotic resistance in Escherichia coli.Mol Microbiol. 1996 Aug;21(3):441-8. doi: 10.1111/j.1365-2958.1996.tb02553.x. Mol Microbiol. 1996. PMID: 8866468 Review.
Cited by
-
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.Antimicrob Agents Chemother. 2007 Feb;51(2):535-42. doi: 10.1128/AAC.00600-06. Epub 2006 Oct 16. Antimicrob Agents Chemother. 2007. PMID: 17043131 Free PMC article.
-
Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates.Antimicrob Agents Chemother. 2005 Oct;49(10):4390-2. doi: 10.1128/AAC.49.10.4390-4392.2005. Antimicrob Agents Chemother. 2005. PMID: 16189130 Free PMC article.
-
Using In Vitro Dynamic Models To Evaluate Fluoroquinolone Activity against Emergence of Resistant Salmonella enterica Serovar Typhimurium.Antimicrob Agents Chemother. 2017 Jan 24;61(2):e01756-16. doi: 10.1128/AAC.01756-16. Print 2017 Feb. Antimicrob Agents Chemother. 2017. PMID: 27895011 Free PMC article.
-
The complex development of psoralen-interstrand crosslink resistance in Escherichia coli requires AcrR inactivation, retention of a marbox sequence, and one of three MarA, SoxS, or Rob global regulators.bioRxiv [Preprint]. 2024 Dec 7:2024.12.03.626702. doi: 10.1101/2024.12.03.626702. bioRxiv. 2024. Update in: Mutat Res. 2025 Jan-Jun;830:111898. doi: 10.1016/j.mrfmmm.2025.111898. PMID: 39677732 Free PMC article. Updated. Preprint.
-
AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity.Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3511-6. doi: 10.1073/pnas.1419939112. Epub 2015 Mar 3. Proc Natl Acad Sci U S A. 2015. PMID: 25737552 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases